The initial success of Viagra undeniably revolutionized the pharmaceutical landscape, but betting in companies heavily reliant on off-patent versions presents a uncertain picture. Although early earnings were significant, the cessation of patents and the rise of cheaper alternatives have diminished market share. Thus, a thorough assessment of prese